However, XLH diagnosis is often delayed or mistaken due to nonspecific symptoms, while TIO diagnosis is complicated by the challenge of localizing small FGF23-secreting tumors, which requires extensive imaging. This evidence concerns the gene FGF23 and X-linked hypophosphatemia.